SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001354488-15-001301
Filing Date
2015-03-24
Accepted
2015-03-24 09:03:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tbuff_sc13d.htm SC 13D 128010
2 AGREEMENT OF JOINT FILING tbuff_ex1.htm EX-1 7529
3 AMENDING AGREEMENT tbuff_ex7.htm EX-7 18256
  Complete submission text file 0001354488-15-001301.txt   155424
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Subject) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79704 | Film No.: 15720558
SIC: 2834 Pharmaceutical Preparations

Mailing Address 82 WATER STREET EAST ELORA A6 N0B1S0
Business Address 57 MARTIN STREET MILTON A6 L9T2R1 5198311491
Elora Financial Management Inc. (Filed by) CIK: 0001536874 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0930
Type: SC 13D